Lagenariasiceraria (Molina) Standley (Cucurbitaceae) is a traditional vegetable plant, popularly known as bottle gourd (English) and lauki (Hindi). It is a climbing herb characterized with a number of therapeutic properties. Traditionally Lagenariasiceraria (LS) fruits were used for their cardioprotective, hepatoprotective, diuretic, and purgative effects, but there is very little scientific data available on its neuroprotective potential.

Download full-text PDF

Source
http://dx.doi.org/10.3897/folmed.64.e59492DOI Listing

Publication Analysis

Top Keywords

molina standley
8
vegetable plant
8
neuropharmacological evaluation
4
evaluation hptlc
4
hptlc fingerprint
4
fingerprint profile
4
profile phytocompound-enriched
4
phytocompound-enriched chloroform
4
chloroform fraction
4
fraction methanolic
4

Similar Publications

(Molina) Standley, a member of the Cucurbitaceae family, is valued for its medicinal and nutritive properties. The nutrient status of sequentially harvested shoots and fruits at various growth stages in has not been documented to date. This study aimed to compare the nutritional status of landrace shoots and fruits harvested at different maturity stages.

View Article and Find Full Text PDF

Defatted Lagenaria siceraria seed flour (DLSSF) was obtained from defatted seed cake, dried, and ground through a sieve of 500 μm and characterized. A 2 × 4 factorial design (two flour hydration rates and four fat substitution rates) was used to produce a low-fat beef patty by replacing fat with DLSSF. Beef kidney fat was used to formulate the control sample.

View Article and Find Full Text PDF

(Molina) Standley is a food and medicinal source with anti-proliferative, anti-fertility, anti-HIV and anti-cancerous properties. The current study investigated the phytochemical constituents of L. fruits using gas chromatography/mass spectrometry (GC-MS).

View Article and Find Full Text PDF

Background: Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS), also known as multisystem inflammatory syndrome in children (MIS-C) emerged in April, 2020. The paediatric comparisons within the RECOVERY trial aimed to assess the effect of intravenous immunoglobulin or corticosteroids compared with usual care on duration of hospital stay for children with PIMS-TS and to compare tocilizumab (anti-IL-6 receptor monoclonal antibody) or anakinra (anti-IL-1 receptor antagonist) with usual care for those with inflammation refractory to initial treatment.

Methods: We did this randomised, controlled, open-label, platform trial in 51 hospitals in the UK.

View Article and Find Full Text PDF

Background: Empagliflozin has been proposed as a treatment for COVID-19 on the basis of its anti-inflammatory, metabolic, and haemodynamic effects. The RECOVERY trial aimed to assess its safety and efficacy in patients admitted to hospital with COVID-19.

Methods: In the randomised, controlled, open-label RECOVERY trial, several possible treatments are compared with usual care in patients hospitalised with COVID-19.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!